News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Molecular Response (MRL) Expands Clinical Offerings with BRAF Mutation Testing



8/18/2011 9:13:46 AM

SAN DIEGO--(BUSINESS WIRE)--Molecular Response announced today that it has launched a clinically validated BRAF test to detect the V600E mutation in both melanoma and colorectal tumors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES